Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revelation Biosciences Inc (NQ: REVB ) 2.110 -0.040 (-1.86%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 31,377 Open 2.120 Bid (Size) 2.020 (2) Ask (Size) 2.290 (1) Prev. Close 2.150 Today's Range 2.090 - 2.330 52wk Range 0.2770 - 25.26 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini June 13, 2024 From Revelation Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session May 17, 2024 Via Benzinga Performance YTD +313.73% +313.73% 1 Month +10.47% +10.47% 3 Month -11.72% -11.72% 6 Month +309.47% +309.47% 1 Year +102.88% +102.88% More News Read More REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024 May 10, 2024 Via InvestorPlace Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024 May 10, 2024 From Revelation Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session April 22, 2024 Via Benzinga REVB Stock Earnings: Revelation Biosciences Beats EPS for Q4 2023 March 22, 2024 Via InvestorPlace Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023 March 22, 2024 From Revelation Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session March 14, 2024 Via Benzinga Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024) March 13, 2024 From Revelation Biosciences Inc. Via Business Wire Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference March 12, 2024 From Revelation Biosciences Inc. Via Business Wire Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini March 04, 2024 From Revelation Biosciences Inc. Via Business Wire Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024) February 13, 2024 From Revelation Biosciences Inc. Via Business Wire Top 5 Health Care Stocks That Are Preparing To Pump In February February 09, 2024 Via Benzinga BioMedNewsBreaks – Revelation Biosciences Inc. (NASDAQ: REVB) Secures ~$6.2M in Public Offering February 08, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Wednesday's After-Market Session February 07, 2024 Via Benzinga Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering February 05, 2024 From Revelation Biosciences Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session February 05, 2024 Via Benzinga Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 02, 2024 Via Benzinga Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket February 02, 2024 Via Benzinga Dow Jumps 250 Points; Honeywell Issues Weak Forecast February 01, 2024 Via Benzinga Topics Stocks Exposures US Equities Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 01, 2024 Via Benzinga Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations February 01, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000 February 01, 2024 Via Benzinga Topics Stocks Exposures US Equities Citi Is Souring on Qualcomm (QCOM) Stock February 01, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
